Table 3.
Method of assessment | N evaluable patients | CR, % | 95% CI (Clopper Pearson) | ORR, % | 95% CI (Clopper Pearson) |
---|---|---|---|---|---|
CT | 24 | 25.0 | (9.8; 46.7%) | 87.5 | (67.6; 97.3%) |
PET/CT | 19 | 68.4 | (43.4; 87.4%) | 84.2 | (60.4; 96.6%) |
Method of assessment | N evaluable patients | CR, % | 95% CI (Clopper Pearson) | ORR, % | 95% CI (Clopper Pearson) |
---|---|---|---|---|---|
CT | 24 | 25.0 | (9.8; 46.7%) | 87.5 | (67.6; 97.3%) |
PET/CT | 19 | 68.4 | (43.4; 87.4%) | 84.2 | (60.4; 96.6%) |